On Thursday, April 7, industry leaders and academic experts, top global researchers and medical professionals, as well as innovators in the healthcare and biotechnology sectors, will convene at the New York Tech Biotechnology Summit, “Transforming and Improving the Human Condition.”
Company representatives and New York Tech faculty will discuss their latest state-of-the art innovations and cutting-edge research transforming and improving the human condition, while government officials and investors discuss how to tap into financial resources to fund startups and accelerate growth.
This second annual summit is sponsored by New York Tech’s College of Engineering and Computing Sciences and the intellectual property law firm of Carter, DeLuca & Farrell LLP.
This in-person event will be held at NYIT de Seversky Mansion and also streamed online. Register for the summit here: https://alumni.nyit.edu/events/2122/biotechnology-conference-registration.
Panels and panelists for the full-day event include:
Keynote Speaker: Chad Bouton, Vice President, Feinstein Institutes for Medical Research at Northwell Health and CEO, Neuvotion.
Panel I: The Startup Ecosystem: Government and Industry Resources for Helping Biotech Companies Succeed
• Babak Dastgheib-Beheshti, Ph.D., Dean, College of Engineering and Computing Sciences (Moderator)
• T3 Advisors representative
• New York City Economic Development Office, Life Sciences representative
• Carmella Stephens, Ph.D., Esq., Partner and Head of Life Sciences, Carter, DeLuca & Farrell LLP
• Robert (Bob) Wild, COO, Intelligent Product Solutions
• Charles R. Goulding, CPA, Esq., President, R&D Tax Savers
New York Tech Speakers
• John Handrakis, D.P.T., Ed.D.: thermoregulatory dysfunction in persons with spinal cord injury
• Shenlong Zhang, Ph.D.: development and commercialization of direct RNA sequencing technology
Panel II: Executives and Founders Discuss Their Companies’ Innovations
• Michael Nizich, Ph.D., Director of the Entrepreneurship and Technology Innovation Center (ETIC), New York Institute of Technology (Moderator)
• Sonsy Rajan, Esq., Head of Intellectual Property Affairs, FUJIFILM Cellular Dynamics, Inc.
• George Llado, Senior Vice President, Integration and Innovation, AstraZeneca Pharma
• Tony Martins, MSEE, President & COO, Avery Biomedical Devices, Inc.
• Ross McBee, Ph.D., Co-Founder and CSO, TOMTEX
New York Tech Speakers
• Aydin Farajidavar, Ph.D.: electroceuticals for mapping and modulating gut activity
• Bryan Gibb, Ph.D.: the need, promise, and status of bacteriophage therapy in the United States
Following a demonstration of innovative technologies being developed in the ETIC, Kevin Tracey, M.D., president, Feinstein Institutes for Medical Research at Northwell Health, will share closing remarks during a networking reception.
